Your browser doesn't support javascript.
loading
Significance of CD103+ tissue-resident memory T cells for predicting the effectiveness of immune checkpoint inhibitors in esophageal cancer.
Natsuki, Seiji; Tanaka, Hiroaki; Nishiyama, Masaki; Deguchi, Sota; Miki, Yuichiro; Yoshii, Mami; Tamura, Tatsuro; Toyokawa, Takahiro; Lee, Shigeru; Maeda, Kiyoshi.
Afiliação
  • Natsuki S; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-Machi, Abeno-Ku, Osaka, 545-8585, Japan.
  • Tanaka H; Department of Gastroenterological Surgery, Fuchu Hospital, Osaka, Japan. hiroakitan@omu.ac.jp.
  • Nishiyama M; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-Machi, Abeno-Ku, Osaka, 545-8585, Japan.
  • Deguchi S; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-Machi, Abeno-Ku, Osaka, 545-8585, Japan.
  • Miki Y; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-Machi, Abeno-Ku, Osaka, 545-8585, Japan.
  • Yoshii M; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-Machi, Abeno-Ku, Osaka, 545-8585, Japan.
  • Tamura T; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-Machi, Abeno-Ku, Osaka, 545-8585, Japan.
  • Toyokawa T; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-Machi, Abeno-Ku, Osaka, 545-8585, Japan.
  • Lee S; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-Machi, Abeno-Ku, Osaka, 545-8585, Japan.
  • Maeda K; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-Machi, Abeno-Ku, Osaka, 545-8585, Japan.
BMC Cancer ; 23(1): 1011, 2023 Oct 20.
Article em En | MEDLINE | ID: mdl-37864146

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Inibidores de Checkpoint Imunológico Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Inibidores de Checkpoint Imunológico Idioma: En Ano de publicação: 2023 Tipo de documento: Article